ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has appointed Stella Panu as non-executive director.
With over 20 years’ experience in corporate finance and investment management, Stella’s expertise will support the ValiRx Board and senior management team to unlock investment potential and accelerate and manage business growth for the company.
In her role, she will also oversee ValiRx’s M&A activity, advising on corporate structure and governance, risk management, and shareholders’ rights.
Stella was a founding partner of investment…
Now is not the time for complacency when it comes to cyber security, warns the National Cyber Security Centre (NCSC) .
Cyber-security is part of Russia’s military doctrine, and whilst the UK has remained relatively unscathed to date, the impact of cyber activity against Ukrainian targets are being felt around the world. For example, Russia was behind a recent cyber-attack on a global communications company, which affected wind farms and internet users across Central Europe.
As a result, the NCSC is encouraging all organisations to respond by maintaining a strengthened cyber-posture.
The…
Located in the West of Scotland Science Park, this new facility will produce fresh leukopaks for cell and gene therapy research in the UK and Europe
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced the opening of its new blood donor center in Glasgow, Scotland. The company’s latest facility is located just outside Glasgow city center in the West of Scotland Science Park, which is home to more than 40 life science and technology businesses. The new donor center will be used primarily for producing LEUKOMAX® leukopaks…
The Cambridge & South Cambs Committee of the Cambridgeshire Chambers of Commerce is running a series of events to tackle the ongoing challenges around recruitment for our Cambridge-based and regional firms.
Starting this week, Thursday 20th October, the first event is being fronted by Nikki Scarr and Danielle Grant from Cambridge-based global life science company, Abcam.
This in-person event, which is being held at the iconic Council Chamber in The Guildhall, Market Square, will focus on the need for companies to adapt to a new working environment and next-generation of employees,…
Berlin Authority published a case law regarding the DPO requirements and the risk of conflict of interest due to the dual position of DPO.
In this case the person was simultaneously the managing director of two service companies that processed personal data on behalf of the company for which he was acting as also data protection officer. These service companies are also part of the group; they provide customer service and execute orders.
The investigation found an alleged conflict of interest concerning the DPO's employment status and decision-making responsibilities that violated Article 38(…
14 October 2022, Tring, UK: SCi Partners, the specialist boutique life science search and interim management partnership, is delighted to have joined One Nucleus.
SCi Partners comprises a highly regarded team of recruitment professionals with a rich heritage in biotech and life sciences, with particular emphasis on leading edge, early-stage, high growth organisations.
The partnership has recently rebranded from Horton International (UK), enabling it to focus on its core business within the life science industry.
Over the last two years, the team has grown rapidly, listening, and…
Arecor Therapeutics plc
(“Arecor”, the “Company” or the “Group”)
HEADLINE RESULTS FROM PHASE I CLINICAL TRIAL OF ULTRA-RAPID ACTING INSULIN CANDIDATE AT247 DEMONSTRATE SIGNIFICANTLY ACCELERATED INSULIN ABSORPTION AND EARLY EXPOSURE COMPARED TO GOLD STANDARD INSULINS NOVOLOG® AND FIASP®
- AT247 delivers significantly accelerated insulin absorption and early exposure (PK profile) compared with NovoLog® and Fiasp®, meeting co-primary endpoint
- AT247 delivers a statistically significant superior glucose lowering effect compared with NovoLog® supporting the accelerated absorption and early…
7th Oct 2022, New Delhi: Thermo Fisher Scientific, the world leader in serving science, recently participated in a conference on the Application of New-age Technologies in Diagnostics organized by the Confederation of Indian Industry (CII) Northern Regional Committee on Diagnostics and Technology.
CII is a non-government, not-for-profit, industry-led organization, that is engaged in creating and sustaining an environment conducive to the development of India.
Aimed at highlighting the present and future of diagnostics, in a lead-up to India’s 100th year of independence, the conference brought…
For 2022 only the Oncology Conference and the Precision Medicine Conference will both run in conjunction with each other. Join Bionow, expert speakers and industry colleagues to discuss the current oncology landscape and the future of precision medicine.
The prevention of cancer and the development of more effective strategies for early-stage detection, when treatment may be most effective, remain critical societal goals. Precision medicine is the next generation of healthcare research that has the potential to provide significant, targeted benefits to patients, and affect strategic shifts in…